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Abstract
Background: Adolescence is characterized by marked psychosocial, behavioural and biological changes
and represents a critical life transition through which adult health and well-being are established.
Substantial research confirms the role of psycho-social and environmental influences on this transition,
but objective research examining the role of puberty hormones, testosterone in males and oestradiol in
females (as biomarkers of puberty) on adolescent events is lacking. Neither has the tempo of puberty, the
time from onset to completion of puberty within an individual been studied, nor the interaction between
age of onset and tempo. This study has been designed to provide evidence on the relationship between
reproductive hormones and the tempo of their rise to adult levels, and adolescent behaviour, health and
wellbeing.
Methods/Design The ARCHER study is a multidisciplinary, prospective, longitudinal cohort study in 400
adolescents to be conducted in two centres in regional Australia in the State of New South Wales. The
overall aim is to determine how changes over time in puberty hormones independently affect the study
endpoints which describe universal and risk behaviours, mental health and physical status in adolescents.
Recruitment will commence in school grades 5, 6 and 7 (10–12 years of age). Data collection includes
participant and parent questionnaires, anthropometry, blood and urine collection and geocoding. Data
analysis will include testing the reliability and validity of the chosen measures of puberty for subsequent
statistical modeling to assess the impact over time of tempo and onset of puberty (and their interaction)
and mean-level repeated measures analyses to explore for significant upward and downward shifts on
target outcomes as a function of main effects.
Discussion The strengths of this study include enrollment starting in the earliest stages of puberty, the
use of frequent urine samples in addition to annual blood samples to measure puberty hormones, and the
simultaneous use of parental questionnaires.
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Abstract
Background: Adolescence is characterized by marked psychosocial, behavioural and biological changes and
represents a critical life transition through which adult health and well-being are established. Substantial research
confirms the role of psycho-social and environmental influences on this transition, but objective research examining
the role of puberty hormones, testosterone in males and oestradiol in females (as biomarkers of puberty) on
adolescent events is lacking. Neither has the tempo of puberty, the time from onset to completion of puberty
within an individual been studied, nor the interaction between age of onset and tempo. This study has been
designed to provide evidence on the relationship between reproductive hormones and the tempo of their rise to
adult levels, and adolescent behaviour, health and wellbeing.
Methods/Design: The ARCHER study is a multidisciplinary, prospective, longitudinal cohort study in 400
adolescents to be conducted in two centres in regional Australia in the State of New South Wales. The overall aim
is to determine how changes over time in puberty hormones independently affect the study endpoints which
describe universal and risk behaviours, mental health and physical status in adolescents. Recruitment will
commence in school grades 5, 6 and 7 (10–12 years of age). Data collection includes participant and parent
questionnaires, anthropometry, blood and urine collection and geocoding. Data analysis will include testing the
reliability and validity of the chosen measures of puberty for subsequent statistical modeling to assess the impact
over time of tempo and onset of puberty (and their interaction) and mean-level repeated measures analyses to
explore for significant upward and downward shifts on target outcomes as a function of main effects.
Discussion: The strengths of this study include enrollment starting in the earliest stages of puberty, the use of
frequent urine samples in addition to annual blood samples to measure puberty hormones, and the simultaneous
use of parental questionnaires.
Keywords: Puberty, Hormones, Adolescent, Cohort studies, Rural health, Behaviour, Wellbeing, Public health,
Protocol, Paediatrics
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Background
Adolescence is a time when interventions have the capacity to make changes in individual health trajectories
[1-3]. The aim of this study is to understand the effects
of longitudinal changes in puberty hormones, especially
the onset and tempo of change, on adolescent health
and well-being. The present paper presents the research
protocol for the study, with an emphasis on the newer
technologies which have made this type of study
possible.
The two prime hormones, or biological measures, of
puberty are testosterone (in boys) and oestradiol (in
girls) [4], [Figure 1]. The dramatic hormone changes of
puberty are a universal and unforgettable experience. Inevitably such a phenomenon prompts many assumptions
about the effects of puberty hormones on wellbeing and
health. However, the authentic, longitudinal effects of
the puberty hormones on human health and wellbeing
in adolescence and in later adult life are not well understood, and remain under-researched. Previous research
has relied on proxy measures of puberty hormonal
changes including self-report of physical change and
physical growth [5].
The major and rapid increases in puberty hormones
mean that repeated hormone measurement is essential
to appraise the relationships between biological variation
in puberty hormones and the concomitant adolescent
health problems and to allow exploration of the biological determinants of individual, social and physical

environmental factors that are prominent in adolescence
[6]. This is the first challenge in research of this nature.
The onset of puberty occurs when testosterone and
oestradiol begin to rise above the levels of childhood.
This event occurs anywhere between the ages of 8 and
13 years [7,8] but chronological age is an unreliable indicator of pubertal stage. The tempo, or time, to complete
the pubertal increase in reproductive hormones is comparatively rapid, between 18 months and four years,
which is too rapid to be characterized by annual or less
frequent blood sampling. Although the impact of variable tempo of puberty on health and wellbeing has not
been well studied (or reported) [9], we propose that
tempo is a key variable mediating the clinical effects of
dynamically changing puberty hormones on adolescent
health and behaviour [10]. It is notable that hormonal
events of puberty are as dramatic in scope and amplitude as more well known examples of rapid hormonal
change that cause defined physical, behavioural and
mental effects such as the menstrual cycle, pregnancy,
castration, anabolic steroid use and the menopause [11-13].
The additional challenges to research on puberty hormones are to create a framework where factors can be
repeatedly studied with minimum reporter burden, and
to ensure that the interactions between factors are
understood and accounted for in order to satisfactorily
interpret outcomes. The factors that have been chosen
for study are those that are objectively measurable as
well as being clinically important and modifiable, thus
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Figure 1 Puberty hormone change and tempo. Shows the pattern of testosterone and oestradiol change during puberty, the puberty
milestones of menarche and Spermarche in relation to puberty stage and how the tempo of puberty may vary between individuals.
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forming the basis of subsequent interventional studies.
These factors are listed below and a brief review of the
factors, how these are interrelated and their roles as
possible aetiological factors, co-variates or predictors
follows [Figure 2].
The Study Variables are:
 Universal aspects of adolescent health and wellbeing

which include social and emotional wellbeing,
educational engagement and motivation, and sleep.
 Health risk behaviours which include unintentional
injury, alcohol and other drugs, sexual activity and
conduct disorder.
 Mental health which includes depression, anxiety
and self harm.
 Physical health which includes chronic illness and
disability and cardiovascular risk factors –
overweight, physical inactivity and tobacco use.

Universal aspects of adolescent health and wellbeing

Socially competent adolescents are more likely to do
well in education and less likely to have mental health
problems [14]. Learning and engagement in education in
adolescence is critical to social and emotional development and well-being, but the influence of the onset of
and tempo of pubertal hormone rise on motivation and
engagement in education, particularly when compared
with the effects of socio-economic status and mental
health, is as yet unknown [15]. Sleep disturbances in
adolescents are common and may affect school performance and mood. The most common adolescent sleep disorder is delayed sleep phase syndrome (5-10%) [16].
What is not known is how the onset and tempo of pubertal hormone changes relate to sleep alterations and
disturbances [17].
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Health risk behaviours

Unintentional injury is the most common cause of death
in adolescents [18], mainly as a result of road traffic
accidents [19], poisoning and drowning. Previous work
has highlighted possible associations between pubertal
stage as estimated by direct physical examination and
physical injury incidence [20], but the onset of and the
rate of the rise in pubertal hormones have yet to be
studied in this context. Drug and alcohol use in adolescence increases the likelihood for reduced educational
attainment, co-morbid mental health disorders, substance abuse and dependence, criminality, and psychiatric disorders in adulthood [21]. We propose that
puberty onset and tempo also play an important role in
these associations [22]. Sexual activity in teenagers is occurring at younger ages and teenagers are more likely to
report multiple partners than in previous generations
[23]. The relative contribution of changing pubertal hormone levels, specifically tempo, to sexual activity has not
been confirmed and the mechanism of their influence
and modifiers are completely unknown. Conduct disorders appear in pre-puberty or first emerge in puberty
[24]. There are conflicting data about these disorders
and their relationship to early or late maturation as measured by self report and single measurements of blood
testosterone levels.

Mental health

Depression and anxiety are the most common mental
health problems in young people. At any time point, up
to five percent of adolescents experience depression severe enough to warrant treatment, and around 20% of
adolescents will have experienced significant depressive
symptoms by adulthood [25,26]. On self reported Tanner
Stages, depression occurs most commonly at Stage 3 in

Internal hormone environment of PUBERTY,
INCLUDING TEMPO AND ONSET as defined by
blood and urine testosterone & oestradiol

Affected by other events =
AETIOLOGICAL FACTORS
e.g. genetic background, body weight
and composition & physical illness

Has an effect on events in adolescence
= PREDICTOR
e.g. learning, disruptive behaviour,
unintentional injury, depression

Hormone changes parallel other events in adolescence = CO-VARIATE
e.g. sleep cycle alteration, depression, blood pressure

External influences on adolescence health and wellbeing which act as confounders
include socioeconomic status, family and broader environments and external stressors

Figure 2 Depicts how the hormonal environment of puberty as defined by blood and urine testosterone and oestradiol may be
related to the events of adolescence.
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girls and before Stage 3 in boys. There is conflicting evidence about whether age of onset of puberty influences
depression [27-29]. Higher rates of self-harm are found
among adolescents in self-reported late puberty compared to early puberty [30]. The association is mediated
by depressive symptoms, sexual activity and alcohol intake, and often attenuates with increasing age [31].
Physical health

Fifteen percent of adolescents have a chronic physical illness or disability [32]. If serious this may retard the
onset of puberty and potentially alter tempo [33]. Overweight, physical inactivity and tobacco use, which are
the top three contributors to the burden of disease in
developed countries [34], all increase during adolescence
[35]. Twenty percent of adolescents smoke by the age of
17 years [36]. There are no longitudinal studies on how
the age of onset and rate of change or tempo of puberty
hormones influence the cardiovascular risk factors of
overweight, physical inactivity and tobacco use.

Methods/Design
Introduction

The ARCHER study is a multidisciplinary, three year,
longitudinal cohort study, using a convenience sample.
The research hypothesis of the study is that onset and/
or tempo of the rise in puberty hormones play a significant
role in adolescent health and wellbeing. The ARCHER
study commenced recruitment in June 2011 and has
enrolled 200 adolescent participants (with parent/guardian)
as of March 2012.
A feasibility study for all aspects of baseline data collection was completed in 28 students in years 5&6 at a
rural primary school. Sample collection, labeling, transport and storage were successful. The plasma testosterone and oestradiol levels demonstrated that the
participants (except 2 -1 M, 1 F) had levels consistent
with pre- or very early puberty. On-line questionnaires
were revised and successfully re-piloted in August 2009
in a rural primary school with 26 students and their parents. In 2010 focus group discussions (single and mixed
gender with 10–12 year olds and 13–15 year olds) were
held with 58 participants. Topics included what would
positively influence recruitment and retention, how
peers might participate in the study and the collection of
biological samples. The young people expressed strong
preferences in relation to the collection process and the
focus group outcomes are now published [37]. The
methodology was further tested in 2010 in a funded pilot
study on puberty, sleep and depression, with included
the use of the Actiwatch. This is a digitally integrated
recording of wrist activity which provides more detailed
information on sleep wake/times [38].
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Setting and study sample

The study is being conducted in Dubbo and Orange,
two large towns in regional Australia in the State of
New South Wales and surrounding areas. Enrollment is
in school Grades 5, 6 and 7 (10–12 years of age) to ensure that both the transition into early puberty and the
end of puberty are captured in adequate numbers. Each
student will require a parent or guardian to also participate in the study. Lack of parental competence in
English or adolescent intellectual disability are exclusion
criteria. The least common primary outcome that we
measure is depression, which we estimate will affect 5%
of children in mid- to late-puberty [39]. We estimate
that 160 boys and 160 girls at Tanner Stage 3 (the pubertal stage where clinical onset of depression is most
likely) are required to detect a one standard deviation
(SD) difference in testosterone nmol/l (SD = 5) [40] or
oestradiol pmol/l (SD = 250) [41] levels between those
with and without depression. The anticipated loss to follow up is 5% per annum in this setting. Assuming a
mean age of puberty onset of 11.4 years [42], 400
subjects will ensure adequate numbers of adolescents at
Tanner Stage 3 in the study, as a few younger subjects may
not reach this Stage at the end of the study (age 14 years)
and some older children may have already entered Stage 3
at the beginning of the study (age 12 years).
Recruitment procedures and follow up rates

Recruitment is primarily through schools, as well as
through the media (targeted at parents) and through
established links with local community groups. We
have permission from the state Department of Education
and Communities - Western Region and the Catholic
Education Office – Bathurst Diocese to recruit through
their schools. Data collection does not take place in the
schools. Information sessions are held in the community
and at consenting schools. Parents are asked to provide
two additional adult contact names with the written
consent, to reduce loss to follow up. Participants who
agree are sent birthday cards, updates and study
newsletters as reminders by their preferred mode of
contact (email, letter or Short Message Service
(SMS)). These practices have been shown to increase
retention rates in school age children [43]. The young
people requested ‘get togethers’ in the focus groups to
celebrate their involvement in the study and these will
be held annually.
Data collection

Adolescents will complete questionnaires at baseline and
annually for the following three years. We will use a
computerized on-line questionnaire with branched algorithmic structure, to enhance confidentiality and accuracy of responses and to reduce exposure to sensitive
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questions (particularly related to sexual activity). This
has been created and trialed. The total number of questions for adolescents is 256. These are completed in approximately one hour (shorter for the older participants
and closer to 75 minutes for younger participants). Adolescents complete the questionnaire under supervision
of research staff. Questionnaires will not be performed
in the fasted state and, as with all other data and biological sample collection, are done outside school hours.
Physical examination occurs at baseline and annually for
three years. Blood is collected at baseline and annually
for three years, in the fasting state. A first morning urine
sample is collected at baseline and every three months
for three years. A single indicator question providing information on mood fluctuation is sent to all participants
with access to mobiles phones every 3 months and functions as a reminder to complete urine collection.
A parent or guardian completes a questionnaire at
baseline and annually for three years, and in the same
month as their child. The questionnaires are available
online or as hard copy and contain approximately 180
questions. This questionnaire reduces reporter burden
on adolescents for demographic data, as well as providing other relevant family and environmental data.
Ethics

Ethical approval has been granted for the pilot questionnaires, anthropometry, biological sample collection (HREC
10612), the pilot SMS and sleep studies (HREC 12502) and
for the full study described in this protocol (HREC 13094)
from the Human Research Ethics Committee, University of
Sydney.
Instruments
Questionnaires - adolescent

The Child Behaviour Check List (CBCL) in the version
validated for ages 11–18 years as the Youth Self Report
(YSR) [44] is the main questionnaire measurement instrument. It contains 20 social competence items that
measure participation in hobbies, games, sports, jobs,
chores, friendship, and activities and 8 sub-scales, measuring internalizing and externalizing behaviour. In
addition the subscales provide data on social competence, learning and engagement in education, sleep, unintentional injury, drug and alcohol use, conduct
disorders, disruptive behaviour disorders, depression and
anxiety, and self harm. The YSR also identifies the presence of physical illness and disability.
The YSR is supplemented by the following questionnaires.
a) Selected measures of self competency taken from the
Raine cohort [45], including Cowen’s Self Efficacy
[46] and Adolescent Self Perception Profile [47].
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b) 12 selected items from Motivation and Engagement;
Enjoyment of School, Academic Buoyancy and Class
Participation scales [48,49]. These results can be
linked to the Australian National Assessment
Program Literacy and Numeracy scores [50].
c) A questionnaire is used to document sleep/wake
patterns, and sleep disorders in the adolescent’s
natural sleeping environment [51]. In addition, a
convenience subset of adolescents will use the
Actiwatch home monitor system annually.
d) Direct questions on unintentional injury type in the
preceding 12 months provided by RI, selected
questions from The Australian School Students Drug
& Alcohol Survey [52], branched age appropriate
sexuality questions on romantic relationships, sexual
feelings, history of STI and pregnancy [23] and the
40 item validated Australian self-reported
delinquency scale by Mak [53] in those adolescents
who score highly on the YSR subscale for
externalizing problems.
e) The Short Moods and Feeling Questionnaire (13
item) in all subjects [54]. The short form has been
validated as a self-reported unidimensional measure
of symptom severity of childhood depression in
community samples.
f ) The 16 item Deliberate Self Harm inventory [55] for
those who respond with a 1 or 2 for YSR item 18 or
91 (relating to self-harm or suicide).
g) Selected questions from Health Behaviors in Schoolaged Children for physical inactivity, nutrition and
tobacco [56].
h) One SMS question which is a linear analogue selfassessment scale question on mood providing
information on mood fluctuation [57].
i) Tanner Stage of puberty by self report using
standardized line drawings which allow determination
of accuracy of this method of pubertal staging, which
is the main method used in epidemiological and nonclinical studies.
Questionnaires – parent/guardian

a) Demographic data for family and adolescent.
b) Child Behavior Checklist (CBCL) validated
questionnaire for parents of children aged 6–18 years
to corroborate the adolescent’s YSR [58].
c) The validated Macmaster’s Family Assessment
Device [59] to obtain information on family and local
environmental factors, which are potential
confounders.
After the final 3-year questionnaire all adolescents will
be asked whether they believed that the speed of their
puberty was faster, the same as or slower than their age
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peers and whether the onset of their puberty was earlier,
the same as or later compared to their age peers. Their
parent/guardian will be asked the same questions in relation to their child.
Physical examination – adolescents only

Weight and body composition is measured in light
clothing using Tanita TBF-300 Pro Body Composition
Analyzer [60]. Height, and foot length as an indicator of
growth stage [61] are measured on a portable stadiometer (to 0.1 cm) and with a metal ruler (to 0.5 cm) respectively, and waist [62] with a tape (to 0.1 cm) using
standard techniques. Body Mass Index, as a measure of
overweight (kg/m2) and waist circumference are
expressed as individual z-scores based upon age and sex
related reference charts [63]. Blood pressure (BP) and
pulse rate are measured using an automated BP monitor,
under standardised conditions.
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Urine

A first morning, fasting urine sample will be collected at
home. Urinary testosterone and oestradiol will be measured, also using AP5000 LC Tandem MS. Urinary hormones, although less well standardized than blood, are
essential to define hormone trajectories which can never
be accomplished by a single annual sample. Sperm
(indicating spermarche) will be measured in male urine
samples [68]. There will be adequate urine to measure
creatinine and microalbumin, but these measures are
not integral to the current study.
Geocoding

Residential address will be geocoded [69] to obtain additional information such as neighbourhood socioeconomic status, access to services and amenities and other
environmental exposures, which may be study confounders for which adjustment will be required.
Statistical analysis

Laboratory – adolescents only

Fasting bloods are collected using local anaesthetic
cream and separated serum and spot urine samples frozen at −80°C, as well as buffy coat in one sample. Total
blood draw is approximately 30 ml. Menstrual cycle
stage will be recorded in post-menarchal females, with
the perimenstrual week avoided.
Blood

Testosterone and oestradiol will be measured using
AP5000 LC Tandem MS in the Andrology laboratory,
ANZAC Research Institute [64] (DHEA, DHT and oestrone
will also be measured). There will be adequate blood
collected to measure other potential biological variables of interest, which will form the basis of future
studies but which are not integral to this study. These
variables include LH, FSH, SHBG and IGF-1, inhibin,
anti-Mullerian hormone, ACTH, cortisol, growth hormone, prolactin, oxytocin, TSH, thyroxine, triiodothyronine and Vitamin D (all of which are hormones relevant to
puberty) [4], full blood count, ferritin, glucose, liver function, urea, electrolytes, full lipid profile, creatinine,
and insulin, fatty acid profile, leptin, adiponectin, resistin, TNF alpha, CRP and Interleukin 6 (as indicators of
cardiovascular risk and also to derive eGFR) [65]. There
is the potential to be able to study genes relevant to
puberty and sex steroid action; KiSS-1, KAL1, FGFR1,
GnRHR, GRPR-54, TAC3, neurokininB, androgen and
oestrogen receptor, steroidogenic enzymes such as CYP,
StAR, P450scc, P450 (17alpha) and 17beta-HSD [66],
and genes relevant to body composition and insulin
resistance, such as leptin gene and product, MC4R,
FTO, IL-6, and UCP-2 [67].

The main independent variables are tempo of puberty
and age of onset at puberty. Both will be measured by
testosterone and oestradiol, in blood and urine. Data
analysis will have three main components.
1) The first component is testing the reliability and
validity of measures under focus. These analyses
will centre on: (a) descriptive, reliability and item
functioning; (b) factor analysis to test factor
structure and validity of measures; (c) ANOVAs for
preliminary tests of main and interaction effects of
background socio-demographics; and (d) tests of
(in)variance in factor structure to ensure
congruence in measurement properties across subgroups to justify pooling sample data for
subsequent modeling throughout the project [70].
2) The second component is a correlational one and
assesses the impact of tempo and onset of puberty
over time. Specifically, for example, by assessing in
the one analytic model (eg. in linear regression
models for continuous variables such as YSR
scores for sensation seeking and in logistic
regression models for dichotomous outcomes such
as depression or sexual debut) the effects of Time
1 onset and tempo of puberty on Time 2 outcomes
after controlling for Time 1 outcomes, it is possible
to get a sense of the relative salience of the onset,
and tempo of puberty in one time period over
factors in a following time period [71]. Also in
these longitudinal analyses, key socio-demographic
(and other) factors such as gender, school grade
and socioeconomic factors can be included to get a
further sense of puberty by controlling for other
potential influences. The three monthly urine
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samples for the biological markers of puberty can
be used to regress time on time measures, with
tempo being defined by the residuals. Thus the
larger and the more positive a residual over time,
the more rapid the tempo of change.
3) The third component is based on mean-level
differences (e.g. repeated measures) and explores
for significant upward and downward shifts in
means on target outcomes as a function of main
effects (e.g. early and late onset; rapid and slow
tempo) and interactions (e.g. early onset/rapid
tempo; late onset/rapid tempo; early onset/slow
tempo and late onset/slow tempo) of puberty
effects that also control for key socio-demographic
(and other) factors as covariates [72]. Taken
together, these analyses (and adaptations of them)
allow for integrative tests of the substantive and
methodological issues at hand.
Analyses will be conducted using SAS, Stata and
WinBUGS (for repeated measures analyses).

Discussion
This study aims to extend previous puberty research
which has sought to consider the relationship between
the biological events of puberty and the complex, longer
state of adolescence and its associated health issues. As
a longitudinal study it commences at a younger age in
order to capture the transition into puberty, as defined
by the first elevations of testosterone and oestradiol in
blood and urine. Thus puberty is defined using biological
markers, which are of fundamental importance to the
project. Previous studies have relied on self report of pubertal stage, which is a lagging and insensitive measure,
that correlates only weakly with measured puberty hormones [5]. This will be the first study to focus on the
biological tempo of puberty and its impact on adolescent
health and wellbeing, with frequent biological sampling
and the introduction of new, ultrasensitive state-of-theart, mass spectrometric steroid assays. Previous studies
have used immunoassay with unextracted serum, which
has proven analytically inaccurate and unreliable (although
faster) and which further places in doubt previously
described relationships between the clinical features of
puberty and its hormonal determinants.
The utility of this new knowledge, by the translation of
hormone data into real life, is to better direct interventions at a time when developmental trajectories remain
plastic and capable of alteration and without the need
for biological sample collection. It can be done because
‘puberty phenotypes’ such as early or late onset (out of
step with peers) or rapid tempo (rapid physical change)
and which deviate most from average age of onset/average
tempo (similar to the majority) are already recognizable
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using simple observation by clinicians, parents, educators
and adolescents. What is missing is an understanding of
the direction and magnitude of influence of intrinsic
tempo and timing of puberty on adolescent behaviour,
wellbeing and health and how hormonal changes interact
with external factors. The indirect, non-biological evidence
is that the magnitude of intrinsic hormonal influence is
significant.
There is no suggestion that altering the onset or
tempo of puberty is a realistic intervention (despite its
feasibility using modern steroidal or gonadotrophin releasing hormone analogue therapy [73,74]). It is however
of great interest to determine whether the dynamic hormonal changes of puberty trigger behavioural or physical
problems. If puberty hormones do have an effect, it
would be possible to target established, evidence-based
directed interventions to at-risk adolescents, presumably
those whose puberty patterns are dissimilar to the majority. These could include evidence-based interventions
in sleep hygiene, unintentional injury, mental health, and
cardiovascular risk. In schools, where year levels are
defined by age, rather than pubertal stage, information
will be provided to better assist school personnel to
identify and deal with the wide developmental range in
any given year group. Adolescents, their parents and
families will benefit from understanding how hormones
influence adolescent behaviours. The community will
benefit if knowledge gained from this study is used to
improve adolescents’ health and wellbeing.
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